Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

Bibliographic Details
Main Authors:	Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno
Format:	Article
Language:	English
Published:	BMC 2024-03-01
Series:	Cardiovascular Diabetology
Online Access:	https://doi.org/10.1186/s12933-024-02190-6

Internet